Suchergebnisse - "Touzeau, Cyrille"

PubPharm (15)

1

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma : final analysis of PLEIADES and EQUULEUS

enthalten in: Blood cancer journal | 2023

von Moreau, P. | Chari, A. | Oriol, A. | +25

2

T-cell-redirecting bispecific antibodies in multiple myeloma : a revolution?

enthalten in: Blood | 2022

von Moreau, P. | Touzeau, C.

3

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA

enthalten in: Leukemia | 2022

von Facon, T. | Cook, G. | Usmani, S. | +25

4

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

enthalten in: Blood | 2022

von San-Miguel, J. | Avet-Loiseau, H. | Paiva, B. | +24

CommentIn: Blood. 2022 Jan 27;139(4):469-471. - PMID 35084473

5

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA) : an open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Moreau, P. | Hulin, C. | Perrot, A. | +49

CommentIn: Nat Rev Clin Oncol. 2021 Nov;18(11):676. - PMID 34545220

6

Exposure-Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients

enthalten in: Journal of clinical pharmacology | 2021

von Luo, M. | Usmani, S. | Mateos, M. | +12

7

Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma

enthalten in: American journal of hematology | 2021

von Kaufman, J. | Gasparetto, C. | Schjesvold, F. | +18

8

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES) : an open-label Phase II study

enthalten in: British journal of haematology | 2021

von Chari, A. | Rodriguez-Otero, P. | McCarthy, H. | +18

9

Carfilzomib in combination with daratumumab in the management of relapsed multiple myeloma

enthalten in: Future oncology (London, England) | 2021

von Touzeau, C. | Antier, C. | Moreau, P.

10

Monoclonal antibodies as an addition to current myeloma therapy strategies

enthalten in: Expert review of anticancer therapy | 2021

von Jullien, M. | Touzeau, C. | Moreau, P.